Back to search results

A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

Abroad (travel likely)RecruitingPHASE3

Conditions

Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Flinders Medical Centre, Adelaide, Australia

    Sobieraj-Teague

  • Box Hill Hospital, Box Hill, Australia

    Motorna

  • Canberra Hospital, Canberra, Australia

    Joshi

  • Barwon Health, University Hospital Geelong, Geelong, Australia

    Campbell

  • Austin Hospital, Heidelberg, Australia

    Hocking

  • Nepean Cancer Centre, Kingswood, Australia

    Ponraj

  • Northern Hospital, Melbourne, Australia

    Cooke

  • Sunshine Coast Health, Sunshine Coast, Australia

    Wallington-Gates

  • Ordensklinikum Linz, Linz, Austria

    Strassl

  • Klinik Ottakring, Vienna, Austria

    Schreder

  • University Hospital Centre Zagreb - Clinic for Internal Medicine, Zagreb, Croatia

    Basic-Kinda

  • Fakultni Nemocnice Hradec Kralove, Hradec Králové, Czechia

    Radocha

  • University Hospital Olomouc, Olomouc, Czechia

    Minarik

  • Fakultni Nemocnice Ostrava, Ostrava, Czechia

    Hajek

  • Fakultni Nemocnice Plzen, Pilsen, Czechia

    Jungova

  • Aarhus Universitetshospital, Aarhus, Denmark

    Contact: Study coordinator (Ølholm Vase)

  • North Estonia Medical Centre Foundation, Tallinn, Estonia

    Loigom

  • Tartu University Hospital, Tartu, Estonia

    Pärnat

  • Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

    Söderholm

  • Kuopio University Hospital, Kuopio, Finland

    Partanen

  • Universitaetsmedizin Greifswald, Greifswald, Germany

    Krönke

  • Universitaetsklinikum Schleswig-Holstein -Campus Luebeck - Klinik fuer Haematologie und Onkologie, Lübeck, Germany

    Leitner

  • University Hospital of Würzburg, Würzburg, Germany

    Waldschmidt

  • University Hospital of Alexandroupolis, Alexandroupoli, Greece

    Spanoudakis

  • Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens, Athens, Greece

    Contact: Study coordinator (Evangelos Terpos)

  • Evaggelismos Hospital, Athens, Greece

    Delimpasi

  • Theagenion Cancer Hospital, Thessaloniki, Greece

    Katodritou

  • Cork University Hospital, Cork, Ireland

    Mykytiv

  • Beaumont Hospital, Dublin, Ireland

    Quinn

  • University Hospital Limerick - Department of Haematology, Limerick, Ireland

    Clifford

  • AOU Ospedali Riuniti di Ancona, Ancona, Italy

    Offidani

  • Azienda Ospedaliera Santa Croce e Carle - Ematologia, Cuneo, Italy

    Celeghini

  • A.O.U. Careggi, Florence, Italy

    Antonioli

  • IRCCS Ospedale Policlinico San Martino, Genova, Italy

    Aquino

  • Ospedale di Legnano, ASST Ovest Milanese, Legnano, Italy

    Rezzonico

  • Meldola-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, Italy

    Cerchione

  • ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

    Cafro

  • Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda - Oncologia, Milan, Italy

    Bolli

  • Azienda USL IRCCS Di Reggio Emilia, Reggio, Italy

    Gamberi

  • Ospedale "Infermi" di Rimini, Rimini, Italy

    Rotondo

  • I.R.C.C.S. Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

    Carella

  • Erasmus MC, Rotterdam, Netherlands

    Stege

  • Stavanger University Hospital, Stavanger, Norway

    Haukås

  • St. Olavs hospital HF, Trondheim, Norway

    Slørdahl

  • Vestfold Hospital Trust, Tønsberg, Norway

    Moksnes

  • CHUC, Coimbra, Portugal

    Roque

  • Hospital da Luz Lisboa, Lisbon, Portugal

    Pedrosa

  • Institut Catala D'oncologia (Badalona), Badalona, Spain

    Ibarra

  • Hospital Clinic De Barcelona - Myeloma and Amyloidosis Unit, Barcelona, Spain

    Contact: Study coordinator (Laura Rosiñol Dachs, MD)

  • Hospital Quirón Salud Madrid, Madrid, Spain

    Contact: Study coordinator (Martinez Chamorro)

  • Hospital Universitario Marques De Valdecilla -Hematology and Hemotherapy Service, Santander, Spain

    Contact: Study coordinator (Enrique Ocio San Miguel, MD)

  • Hospital Universitario la Fe, Valencia, Valencia, Spain

    Contact: Study coordinator (de la Rubia)

  • Skåne University Hospital, Region Skåne, Lund, Sweden

    Lemonakis

  • Universitaetsspital Basel - Zentrum fur Hamato-Onkologie, Basel, Switzerland

    Heim

  • Kantonsspital St. Gallen, Sankt Gallen, Switzerland

    Lehmann

  • Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Cengiz Seval)

  • Liv Hospital Ankara, Ankara, Turkey (Türkiye)

    Beksac

  • Ege Universitesi Tip Fakultesi - Hematology, Izmir, Turkey (Türkiye)

    Vural

  • Ege University Medicine Faculty, Izmir, Izmir, Turkey (Türkiye)

    Comert
Study leads

  • Roberto Mina

    Principal Investigator

    A.O.U. Città della Salute e della Scienza di Torino

  • Claudia Stege

    Principal Investigator

    Erasmus Medical Center

View source on ClinicalTrials.gov(opens in a new tab)